Experimental Models on Diabetes: A Comprehensive Review

Vivek Dave, Radha Sharma, Swapnil Sharma, Pankaj Jain, Sachdev Yadav

DOI: http://dx.doi.org/10.5138/ijaps.v4i1.980


Present world scenario globally, upto 2010, around 285 million people suffering from Type 2 diabetes making up about 90% of the cases. According to statistics, by 2030, this number is estimated to almost double. Diabetes mellitus occurs throughout the world, but is more common (especially Type 2) in the more developed countries. The greatest increase in prevalence is, however, expected to occur in Asia and Africa, where most patients will probably be found by 2030. The aim of this review is to summarize several studies done for the discovery of new drug using different animal models for in vivo studies (chemical, surgical, and genetic models ) & in vitro models (glucose uptake, pancreatic islet cell lines and  insulin secretion).


Diabetes mellitus; Malabsorption; Insulin

Full Text:



Gardner D, Shoback D. ‘Greenspan's basic & clinical endocrinology (9th Ed.)’. New York: McGraw-Hill Medical. 2011; 17: 443-468.

Klatt EC, Kumar. V. Robbins and Cotran Review of pathology. Saunders (3)2009; pp148-155

Henry M, Kronenberg MD, Shlomo Melmed MD, Kenneth S. Polonsky MD. ‘Williams’s textbook of endocrinology (12th ed.)’. Philadelphia: Elsevier/Saunders. 2011; pp. 1371–1435.

Wild S, Roglic G, Green A, Sicree R, King H. ‘Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030’. Diabetes Care 2004; (5): 1047–53.

Beretta A. ‘Campanha de prevencao e diagnostic do diabetes realizada pela UNIARARAS eprefeitura municipal na cidade de Araras. Laes and Haes ’2001; (131): A188-200.

Macedo CS, Capelletti SM, Mercadante CS, Padovani CR, Spadella CT. ‘Experimental model of induction of diabetes mellitus in rats’. Plastic surgery, laboratory of plastic surgery, Sao Paulo Paulista School of Medicine. 2005; pp 2-15.

Gale, Jason.‘India’s Diabetes Epidemic Cuts down Millions Who Escape Poverty’. Bloomberg. http://www.bloomberg.com/news/2010-11-07/india-s-deadly-diabetes-scourge-cuts-down-millions-rising-to-middle-class.html.Retrieved8 June 2012.

Global Guideline for Type 2 Diabetes, International Diabetes Atlas www.diabetes atlas.org/International diabetes federation 2012.

Mohan V, Pradeepa R. ‘Epidemiology of diabetes in different regions of India’. Health Administrator. 2009; 22:1–18.

Sarah W, Gojka R, Anders G, Richard S. Hilary King. Diabetes Care. 2004; 27:1047-1053.

Mitra A, Bhattacharya D, Roy SJ. Hum Ecol. 2007; (2):139-147.

Mohan V, Shanthirani CS, Deepa M, Deepa R, Unnikrishnan RI, Datta M. J Assoc of Physicians India. 2006; 54:113-117.

Ramachandran A, Wan MC, Snehalatha C. 2010

Snehalatha, Ramachnadaran. Insight into the Mechanism of Primary Prevention of Type 2 Diabetes: Improvement in Insulin Sensitivity and Beta cell function. ‘Genetic and Epigenetic Basis of Complex Diseases ‘conference in Centre for Cellular and Molecular Biology; December, 2009.

Federiuk IF, Casey HM, Quinn MJ, Wood MD, Ward WK. ‘Induction of type 1 diabetes mellitus in laboratory rats by use of alloxan; route of administration, pitfalls, and insulin treatment’. Comprehensive Medicine 2004; 54: 252-257

Mythili MD, Vyas R, Akila G, Gunasekaran S.‘Effect of streptozotocin on the ultrastructure of rat pancreatic islets’. Microscopy Research and Technique 2004; 63, 274–281.

Patel R, Shervington A, Pariente JA, Martinez-Burgos MA, Salido GM, Adeghate E, Singh J ‘Mechanism of exocrine pancreatic insufficiency in streptozotocin-induced type 1 diabetes mellitus’. Annals of the New York Academy of Sciences 2006; 71–88

Rees DA, Alcolado JC. ‘Animal models of diabetes mellitus’. Diabetic Medicine. 2005, 359- 370.

Lei YC, Hwang JS, Chan CC., Lee CT, Cheng TJ. ‘Enhanced oxidative stress and endothelial dysfunction in streptozotocin-diabetic rats exposed to fine particles’. Environmental Research 2005; 99, 335–343.

Yu WJ, Juang SW, Chin WT, Chi TC, Chang CJ, Cheng J.T. ‘Insulin restores neuronal nitric oxide synthase expression in streptozotocininduced diabetic rats’. Life Science 2000; 68, 625–634.

Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, et al. ‘Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide’. Diabetes 1998; 47: 224-9.

Viana GS, Medeiros AC, Lacerda AM, Leal LK, Vale TG, Matos FJ. ‘Hypoglycemic and anti-lipemic effects of the aqueous extract from Cissus sicyoides’. BMC Pharmacol, 2004;8: 4-9.

Antia BS, Okokon JE, Okon PA. ‘Hypoglyacaemic effect of aqueous leaf extract of Persea Americana (Mill) on alloxan induced diabetic rats’. Indian J. pharmacol. 2005; 37:325-326.

McNeill JH. ‘Experimental models of diabetes’. Informa health care. 1990) pp 10-18

Choi SB, Park CH, Choi MK, Jun DW, Park S. () ‘Improvement of insulin resistance and insulin secretion by water extracts of Cordyceps militaris, Phellinus linteus, and Paecilomyces tenuipes in 90% pancreatectomized rats’ Bioscience, Biotechnology, and Biochemistry’. 2004; 68, 2257– 2264.

Masiello P. ‘Animal models of type-2 diabetes with reduced pancreatic cell mass’. The International Journal of Biochemistry and Cell Biology 2006; 38, 873–893.

Chen D, Wang MW. ‘Development and application of rodent models for type-11 diabetes’. Diabetes, Obesity and metabolism 2005; 7: 307-317.

Wu KK, Huan Y. ‘Diabetic atherosclerosis mouse models’ Atherosclerosis 2007; 191: 241-249.

Clee SM., Attie AD The genetic landscape of type-2 diabetes in mice’. Endocrinology Reviews 2006; 28, 48–83.

Meiton DA ‘Reversal of type 1 diabetes in mice’. The New England Journal of Medicine 2006; 355, 89–90.

Herrath, MG Oldstone M. ‘Interferongama is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus’. The Journal of Experimental medicine.1997; (3): 531-9.

Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H. ‘Virus infection triggers insulin dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response Cell’. 1991;65(2):318-31.

Hansotia T, Duckers DJ.‘GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice’. Regulatory Peptides 2005; 128: 125–134.

Iwashima Y, Abiko A, Ushikubi F, Hata A, Kaku K, Sano H, Eto M. ‘Downregulation of the voltage-dependent calcium channel (VDCC) subunit mRNAs in pancreatic islets of type 2 diabetic rats’. Biochemical and Biophysical Research Communications 2001; 280:923–932.

Storling J, Zaitsev SV,‘Calcium has a permissive role in interleukin-1 _-induced c-jun N-terminal kinase activation in insulinsecreting cells’. Endocrinology 2005;146: 3026–3036.

Zhao YF, Keating DJ, Hernandez M, Feng DD, Zhu Y. Long-term inhibition of protein tyrosine kinase impairs electrophysiology activity and a rapid component of exocytosis in pancreatic cells. Journal of Molecular Endocrinology 2005; 35: 49–59.

Poitout V, Olson LK, Robertson, RP () ‘Insulin-secreting cell lines: classification, characteristics and potential applications’. Diabetes Metabolism 1996; 22: 7–14.

Gupta RK, Kesari AN, Murthy PS, Chandra R, Tandom V, Watal G. () ‘Hypoglycemc and antidiabetic effect of ethanolic extract of level of annona squamora L.; in experimental animals’. Journal of ethnopharmacology. 2005; 99:75-81.

Ashcroft FM, Rorsman P. ‘Molecular defects in insulin secretion in type-2 diabetes’. Reviews in Endocrine and Metabolic Disorders 2004;5: 135–142.

Affourtit C, Brand MD. ‘Stronger control of ATP/ADP by proton leak in pancreatic beta-cells than skeletal muscle mitochondria’. The Biochemical Journal 2006;393: 151–159.

Lelliott C, Vidal-Puig AJ. ‘Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation’. International Journal of Obesity and related Metabolic Disorders 2004;28: 22–28.

Karalee JJ, Anderson RA, Graves DA. ‘Hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes’. Journal of the American College of Nutrition 2001;20: 327–336.

Maddux BA, See W, Goldfine ID, Evans JL. ‘Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of alpha-lipoic acid’. Diabetes 2001;50: 404–410.

Wu KK, Huan Y.‘Diabetic atherosclerosis mouse models’. Atherosclerosis 2007; 191: 241–249.

Haffner SM, Laakso, M.‘Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabeticn subjects with and without prior myocardial infarction’. New England Journal of Medicine 1998; 339:229–234.

Breyer MD, Bottinger E, Brosius FC, Harris RC, Heilig CW, Sharma K. () ‘Diabetic nephropathy: of mice and men’. Advances in Chronic Kidney Disease 2005;12: 128–145.

Davies M J. Insulin secretagogues. Curr. Med. Res. Opin. 2002; 18:22-30.

Del PS, Marchetti P. ‘Beta-cell function and anti-diabetic pharmacotherapy’. Diabetes Metab. Res. Rev. 2007; 23:518-527

Purnell JQ, Weyer C.‘Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity’. Treat. Endocrinol. 2003; 33-47.


  • There are currently no refbacks.


Advanced Research Journals

4/70-71. Black Well HB, AL 30100

Copyright@arjournals.org 2009-2016


Follow @arjournals on Twitter